Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.

[1]  M. Lindsey,et al.  Obesity superimposed on aging magnifies inflammation and delays the resolving response after myocardial infarction. , 2015, American journal of physiology. Heart and circulatory physiology.

[2]  J. Min,et al.  Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans. , 2015, JACC. Cardiovascular imaging.

[3]  C. Serhan,et al.  Protective Actions of Aspirin-Triggered (17R) Resolvin D1 and Its Analogue, 17R-Hydroxy-19-Para-Fluorophenoxy-Resolvin D1 Methyl Ester, in C5a-Dependent IgG Immune Complex–Induced Inflammation and Lung Injury , 2014, The Journal of Immunology.

[4]  Sumanth D. Prabhu,et al.  Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction , 2014, Basic Research in Cardiology.

[5]  J. Backs,et al.  Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway , 2014, Proceedings of the National Academy of Sciences.

[6]  E. Thorp,et al.  Phagocyte-myocyte interactions and consequences during hypoxic wound healing. , 2014, Cellular immunology.

[7]  C. Serhan,et al.  Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. , 2014, American journal of physiology. Cell physiology.

[8]  C. Serhan,et al.  Cutting Edge: Parathyroid Hormone Facilitates Macrophage Efferocytosis in Bone Marrow via Proresolving Mediators Resolvin D1 and Resolvin D2 , 2014, The Journal of Immunology.

[9]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[10]  F. Carvalho,et al.  Impaired resolution of inflammation in human chronic heart failure , 2014, European journal of clinical investigation.

[11]  V. Arroyo,et al.  Resolvin D1 primes the resolution process initiated by calorie restriction in obesity‐induced steatohepatitis , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  Sungeun Kim,et al.  Metabolic Activity of the Spleen and Bone Marrow in Patients With Acute Myocardial Infarction Evaluated by 18F-Fluorodeoxyglucose Positron Emission Tomograpic Imaging , 2014, Circulation. Cardiovascular imaging.

[13]  S. Prabhu,et al.  Integrative Physiology Methods and Results: We Evaluated C57bl/6 Mice with Chronic Hf 8 Weeks after Coronary Ligation. as Compared with Sham-operated Controls, Hf Mice Exhibited: (1) Increased Proinflammatory Cd11b , 2022 .

[14]  S. Prabhu,et al.  Cardiac immune cell remodeling after myocardial infarction. , 2013, Journal of molecular and cellular cardiology.

[15]  M. Lindsey,et al.  Left ventricular remodeling: one small step for the extracellular matrix will translate to a giant leap for the myocardium. , 2013, Congestive heart failure.

[16]  P. Nordbeck,et al.  5-Lipoxygenase facilitates healing after myocardial infarction , 2013, Basic Research in Cardiology.

[17]  M. Perretti,et al.  Proresolving and Tissue-Protective Actions of Annexin A1–Based Cleavage-Resistant Peptides Are Mediated by Formyl Peptide Receptor 2/Lipoxin A4 Receptor , 2013, The Journal of Immunology.

[18]  J. Hensler,et al.  Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice , 2013, American journal of physiology. Heart and circulatory physiology.

[19]  Yunan Tang,et al.  Proresolution Therapy for the Treatment of Delayed Healing of Diabetic Wounds , 2013, Diabetes.

[20]  Nguyen T. Nguyen,et al.  Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction. , 2012, Journal of molecular and cellular cardiology.

[21]  M. Perretti,et al.  Resolvin D1 Limits Polymorphonuclear Leukocyte Recruitment to Inflammatory Loci: Receptor-Dependent Actions , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[22]  M. Spite,et al.  Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. , 2012, Annual review of nutrition.

[23]  C. Serhan,et al.  Specialized Proresolving Mediators Enhance Human B Cell Differentiation to Antibody-Secreting Cells , 2012, The Journal of Immunology.

[24]  Charles P. Lin,et al.  Myocardial infarction accelerates atherosclerosis , 2012, Nature.

[25]  Charles N. Serhan,et al.  Infection Regulates Pro-Resolving Mediators that Lower Antibiotic Requirements , 2012, Nature.

[26]  S. Serrano,et al.  B–helper neutrophils stimulate immunoglobulin diversification and production in the marginal zone of the spleen , 2011, Nature Immunology.

[27]  P. Libby,et al.  Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis , 2012, The Journal of experimental medicine.

[28]  N. Frangogiannis,et al.  Regulation of the inflammatory response in cardiac repair. , 2012, Circulation research.

[29]  C. Serhan,et al.  Emerging roles of resolvins in the resolution of inflammation and pain , 2011, Trends in Neurosciences.

[30]  B. Maskrey,et al.  Mechanisms of resolution of inflammation: a focus on cardiovascular disease. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[31]  B. Chandrasekar,et al.  Docosahexaenoic Acid-Enriched Fish Oil Attenuates Kidney Disease and Prolongs Median and Maximal Life Span of Autoimmune Lupus-Prone Mice , 2010, The Journal of Immunology.

[32]  C. Serhan,et al.  Resolvin D1 binds human phagocytes with evidence for proresolving receptors , 2010, Proceedings of the National Academy of Sciences.

[33]  Fei Wang.  The signaling mechanisms underlying cell polarity and chemotaxis. , 2009, Cold Spring Harbor perspectives in biology.

[34]  J. Barkhausen,et al.  Systematic analysis of functional and structural changes after coronary microembolization: a cardiac magnetic resonance imaging study. , 2009, JACC. Cardiovascular imaging.

[35]  K. Chatila,et al.  CD44 Is Critically Involved in Infarct Healing by Regulating the Inflammatory and Fibrotic Response1 , 2008, The Journal of Immunology.

[36]  J. Uddin,et al.  Resolvin D1 and Its Aspirin-triggered 17R Epimer , 2007, Journal of Biological Chemistry.

[37]  John Savill,et al.  Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.

[38]  Dennis W. Hair,et al.  Light scattering studies of stereocomplex formation of stereoregular poly(methyl methacrylate) in solutions , 2005 .

[39]  M. Reilly,et al.  Patients Exposed to Rofecoxib and Celecoxib Have Different Odds of Nonfatal Myocardial Infarction , 2005, Annals of Internal Medicine.

[40]  T. Huynh,et al.  Inhibition of COX pathway in experimental myocardial infarction. , 2004, Journal of molecular and cellular cardiology.

[41]  J. McMurray,et al.  Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) , 2004, Circulation.

[42]  T. Grosser,et al.  Role of Prostacyclin in the Cardiovascular Response to Thromboxane A2 , 2002, Science.

[43]  J. Kamps,et al.  Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells. , 1999, Biochimica et biophysica acta.

[44]  A. Mantovani,et al.  Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. , 1992, Blood.